John McGrath, Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 6,000 shares at $15.49 ($93K) on 2016-02-16, disclosed to the SEC on 2016-02-18.
Open-market sale of $93k ATRA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2018-01-12 | $901K | — | Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |